| Kidney Renal Clear Cell Carcinoma | KIRC | Atezolizumab | PD-L1 | CD274 | clinical trail | 26755520 | Details |  |  |  |  |
| Kidney Renal Clear Cell Carcinoma | KIRC | Atezolizumab | VEGFA | VEGFA | clinical trail | 26755520 | Details | | | | |
| Kidney Renal Clear Cell Carcinoma | KIRC | Atezolizumab | ferritin | FTL | clinical trail | 26755520 | Details | | | | |
| Kidney Renal Clear Cell Carcinoma | KIRC | Atezolizumab | ferritin | FTH1 | clinical trail | 26755520 | Details | | | | |
| Kidney Renal Clear Cell Carcinoma | KIRC | Atezolizumab | Complement C3 | C3 | clinical trail | 26755520 | Details | | | | |
| Kidney Renal Clear Cell Carcinoma | KIRC | Atezolizumab | vitamin D–binding protein | GC | clinical trail | 26755520 | Details | | | | |
| Kidney Renal Clear Cell Carcinoma | KIRC | Atezolizumab | macrophage inflammatory protein-1a | CCL3 | clinical trail | 26755520 | Details | | | | |
| Kidney Renal Clear Cell Carcinoma | KIRC | Atezolizumab | serum amyloid P component | APCS | clinical trail | 26755520 | Details | | | | |
| Kidney Renal Clear Cell Carcinoma | KIRC | Atezolizumab | a-1-antitrypsin | SERPINA1 | clinical trail | 26755520 | Details | | | | |
| Kidney Renal Clear Cell Carcinoma | KIRC | Atezolizumab | von Willebrand factor | VWF | clinical trail | 26755520 | Details | | | | |
| Kidney Renal Clear Cell Carcinoma | KIRC | Atezolizumab | fibrinogen | FGB | clinical trail | 26755520 | Details | | | | |
| Kidney Renal Clear Cell Carcinoma | KIRC | Atezolizumab | FoxP3 | FOXP3 | clinical trail | 26755520 | Details | | | | |
| Kidney Renal Clear Cell Carcinoma | KIRC | rhIL-37 | IL-6 | IL6 | cell lines | 26464282 | Details | | | | |
| Kidney Renal Clear Cell Carcinoma | KIRC | rhIL-37 | IL-6 | IL6 | cell lines | 26464282 | Details | | | | |
| Kidney Renal Clear Cell Carcinoma | KIRC | rhIL-37 | pSTAT3 | STAT3 | cell lines | 26464282 | Details | | | | |
| Kidney Renal Clear Cell Carcinoma | KIRC | rhIL-37 | Bcl-2 | BCL2 | cell lines | 26464282 | Details | | | | |
| Kidney Renal Clear Cell Carcinoma | KIRC | rhIL-37 | cyclin D1 | CCND1 | cell lines | 26464282 | Details | | | | |
| Kidney Renal Clear Cell Carcinoma | KIRC | rhIL-37 | HIF-1α | HIF1A | cell lines | 26464282 | Details | | | | |
| Kidney Renal Clear Cell Carcinoma | KIRC | rhIL-37 | HIF-1α | HIF1A | cell lines | 26464282 | Details | | | | |
| Kidney Renal Clear Cell Carcinoma | KIRC | rhIL-37 | IL-6 | IL6 | mouse model | 26464282 | Details | | | | |
| Kidney Renal Clear Cell Carcinoma | KIRC | rhIL-37 | IL-6 | IL6 | mouse model | 26464282 | Details | | | | |
| Kidney Renal Clear Cell Carcinoma | KIRC | rhIL-37 | HIF-1α | HIF1A | mouse model | 26464282 | Details | | | | |
| Kidney Renal Clear Cell Carcinoma | KIRC | rhIL-37 | HIF-1α | HIF1A | mouse model | 26464282 | Details | | | | |
| Kidney Renal Clear Cell Carcinoma | KIRC | Newcastle disease virus(NDV) | IRF7 | IRF7 | clinical trail | 29504948 | Details | | | | |
| Kidney Renal Clear Cell Carcinoma | KIRC | Newcastle disease virus(NDV) | MX2 | MX2 | clinical trail | 29504948 | Details | | | | |
| Kidney Renal Clear Cell Carcinoma | KIRC | Newcastle disease virus(NDV) | IFIT2 | IFIT2 | clinical trail | 29504948 | Details | | | | |
| Kidney Renal Clear Cell Carcinoma | KIRC | Newcastle disease virus(NDV) | CXCL9 | CXCL9 | clinical trail | 29504948 | Details | | | | |
| Kidney Renal Clear Cell Carcinoma | KIRC | Newcastle disease virus(NDV) | CXCL11 | CXCL11 | clinical trail | 29504948 | Details | | | | |
| Kidney Renal Clear Cell Carcinoma | KIRC | WR.TK-Luc+ | Tregs | Regulatory T (Treg) cell | mouse model | 27374223 | Details | | | | |
| Kidney Renal Clear Cell Carcinoma | KIRC | WR.TK-Luc+ | Tregs | Natural regulatory T (Treg) cell | mouse model | 27374223 | Details | | | | |
| Kidney Renal Clear Cell Carcinoma | KIRC | WR.TK-Luc+ | Tregs | CD4+CD25+ regulatory T cell | mouse model | 27374223 | Details | | | | |
| Kidney Renal Clear Cell Carcinoma | KIRC | WR.TK-HPGD+ | MDSC | Myeloid-derived suppressor cell | mouse model | 27374223 | Details | | | | |
| Kidney Renal Clear Cell Carcinoma | KIRC | WR.TK-HPGD+ | Tregs | Regulatory T (Treg) cell | mouse model | 27374223 | Details | | | | |
| Kidney Renal Clear Cell Carcinoma | KIRC | WR.TK-HPGD+ | Tregs | Natural regulatory T (Treg) cell | mouse model | 27374223 | Details | | | | |
| Kidney Renal Clear Cell Carcinoma | KIRC | WR.TK-HPGD+ | Tregs | CD4+CD25+ regulatory T cell | mouse model | 27374223 | Details | | | | |
| Kidney Renal Clear Cell Carcinoma | KIRC | WR.TK-HPGD+ | CXCL10 | CXCL10 | mouse model | 27374223 | Details | | | | |
| Kidney Renal Clear Cell Carcinoma | KIRC | WR.TK-HPGD+ | CXCL11 | CXCL11 | mouse model | 27374223 | Details | | | | |
| Kidney Renal Clear Cell Carcinoma | KIRC | WR.TK-HPGD+ | CCL5 | CCL5 | mouse model | 27374223 | Details | | | | |
| Kidney Renal Clear Cell Carcinoma | KIRC | WR.TK-HPGD+ | CXCL12 | CXCL12 | mouse model | 27374223 | Details | | | | |
| Kidney Renal Clear Cell Carcinoma | KIRC | WR.TK-HPGD+ | lift-1 | NA | mouse model | 27374223 | Details | | | | |
| Kidney Renal Clear Cell Carcinoma | KIRC | WR.TK-HPGD+ | lift-2 | NA | mouse model | 27374223 | Details | | | | |
| Kidney Renal Clear Cell Carcinoma | KIRC | WR.TK-HPGD+ | IFN-γ | IFNG | mouse model | 27374223 | Details | | | | |
| Kidney Renal Clear Cell Carcinoma | KIRC | WR.TK-HPGD+ | CTLs | Cytotoxic T cell | mouse model | 27374223 | Details | | | | |
| Kidney Renal Clear Cell Carcinoma | KIRC | WR.TK-HPGD+ | CTLs | CD8+ cytotoxic T cell | mouse model | 27374223 | Details | | | | |
| Kidney Renal Clear Cell Carcinoma | KIRC | WR.TK-HPGD+ | CTLs | CD4+ cytotoxic T cell | mouse model | 27374223 | Details | | | | |
| Kidney Renal Clear Cell Carcinoma | KIRC | WR.TK-HPGD+ | IL12p40+ CD103+ DC | NA | mouse model | 27374223 | Details | | | | |
| Kidney Renal Clear Cell Carcinoma | KIRC | nivolumab | PBRM1 | PBRM1 | clinical trial | 29301960 | Details | | | | |
| Kidney Renal Clear Cell Carcinoma | KIRC | nivolumab | CXCL9 | CXCL9 | clinical trial phase 1b | 27169994 | Details | | | | |
| Kidney Renal Clear Cell Carcinoma | KIRC | nivolumab | CXCL10 | CXCL10 | clinical trial phase 1b | 27169994 | Details | | | | |
| Kidney Renal Clear Cell Carcinoma | KIRC | nivolumab | KLRB1 | KLRB1 | clinical trial phase 1b | 27169994 | Details | | | | |
| Kidney Renal Clear Cell Carcinoma | KIRC | nivolumab | KLRD1 | KLRD1 | clinical trial phase 1b | 27169994 | Details | | | | |
| Kidney Renal Clear Cell Carcinoma | KIRC | nivolumab | KLRG1 | KLRG1 | clinical trial phase 1b | 27169994 | Details | | | | |
| Kidney Renal Clear Cell Carcinoma | KIRC | nivolumab | NKG7 | NKG7 | clinical trial phase 1b | 27169994 | Details | | | | |
| Kidney Renal Clear Cell Carcinoma | KIRC | nivolumab | CD69 | CD69 | clinical trial phase 1b | 27169994 | Details | | | | |